Raymed Labs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported net loss was INR 0.195 million compared to INR 0.162 million a year ago. Basic loss per share from continuing operations was INR 0.0456 compared to INR 0.0379 a year ago. Diluted loss per share from continuing operations was INR 0.0456 compared to INR 0.0379 a year ago.
For the nine months, net loss was INR 0.523 million compared to INR 0.921 million a year ago. Basic loss per share from continuing operations was INR 0.1223 compared to INR 0.2156 a year ago. Diluted loss per share from continuing operations was INR 0.1223 compared to INR 0.2156 a year ago.